GASCOGNE (ALBI.PA) Fundamental Analysis & Valuation

EPA:ALBI • FR0000124414

2.24 EUR
+0.06 (+2.75%)
Last: Mar 10, 2026, 07:00 PM

This ALBI.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALBI. ALBI was compared to 11 industry peers in the Containers & Packaging industry. Both the profitability and financial health of ALBI have multiple concerns. ALBI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. ALBI.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALBI has reported negative net income.
  • ALBI had a positive operating cash flow in the past year.
  • Of the past 5 years ALBI 4 years were profitable.
  • ALBI had a positive operating cash flow in each of the past 5 years.
ALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFALBI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

  • The Return On Assets of ALBI (0.15%) is worse than 63.64% of its industry peers.
  • ALBI's Return On Equity of 0.44% is on the low side compared to the rest of the industry. ALBI is outperformed by 63.64% of its industry peers.
  • ALBI's Return On Invested Capital of 1.31% is on the low side compared to the rest of the industry. ALBI is outperformed by 63.64% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALBI is below the industry average of 6.34%.
Industry RankSector Rank
ROA 0.15%
ROE 0.44%
ROIC 1.31%
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)5.63%
ROE(5y)6.16%
ROIC(3y)4.1%
ROIC(5y)4.24%
ALBI.PA Yearly ROA, ROE, ROICALBI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 0.23%, ALBI is doing worse than 63.64% of the companies in the same industry.
  • ALBI's Operating Margin of 2.17% is on the low side compared to the rest of the industry. ALBI is outperformed by 63.64% of its industry peers.
  • ALBI's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 26.06%, ALBI is doing worse than 81.82% of the companies in the same industry.
  • ALBI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.17%
PM (TTM) 0.23%
GM 26.06%
OM growth 3Y-27.15%
OM growth 5Y-15.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.26%
ALBI.PA Yearly Profit, Operating, Gross MarginsALBI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1

2. ALBI.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALBI is still creating some value.
  • ALBI has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALBI has been increased compared to 5 years ago.
  • Compared to 1 year ago, ALBI has a worse debt to assets ratio.
ALBI.PA Yearly Shares OutstandingALBI.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ALBI.PA Yearly Total Debt VS Total AssetsALBI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • Based on the Altman-Z score of 1.28, we must say that ALBI is in the distress zone and has some risk of bankruptcy.
  • ALBI has a Altman-Z score (1.28) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 1.16 is on the high side and indicates that ALBI has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.16, ALBI is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACC0.4
WACC3.28%
ALBI.PA Yearly LT Debt VS Equity VS FCFALBI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.60 indicates that ALBI should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.60, ALBI perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
  • ALBI has a Quick Ratio of 1.60. This is a bad value and indicates that ALBI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.86, ALBI perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 0.86
ALBI.PA Yearly Current Assets VS Current LiabilitesALBI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2

3. ALBI.PA Growth Analysis

3.1 Past

  • ALBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.10%, which is quite impressive.
  • ALBI shows a small growth in Revenue. In the last year, the Revenue has grown by 7.25%.
  • ALBI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.07% yearly.
EPS 1Y (TTM)102.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.36%
Revenue 1Y (TTM)7.25%
Revenue growth 3Y-0.64%
Revenue growth 5Y0.07%
Sales Q2Q%6.98%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALBI.PA Yearly Revenue VS EstimatesALBI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

0

4. ALBI.PA Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
ALBI.PA Price Earnings VS Forward Price EarningsALBI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • ALBI's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.55
ALBI.PA Per share dataALBI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. ALBI.PA Dividend Analysis

5.1 Amount

  • No dividends for ALBI!.
Industry RankSector Rank
Dividend Yield 0%

ALBI.PA Fundamentals: All Metrics, Ratios and Statistics

GASCOGNE

EPA:ALBI (3/10/2026, 7:00:00 PM)

2.24

+0.06 (+2.75%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners1.62%
Ins Owner ChangeN/A
Market Cap84.40M
Revenue(TTM)404.78M
Net Income(TTM)927.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF 21.52
P/B 0.4
P/tB 0.43
EV/EBITDA 8.55
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.41
FCFYN/A
OCF(TTM)0.1
OCFY4.65%
SpS10.74
BVpS5.6
TBVpS5.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.15%
ROE 0.44%
ROCE 1.94%
ROIC 1.31%
ROICexc 1.32%
ROICexgc 1.36%
OM 2.17%
PM (TTM) 0.23%
GM 26.06%
FCFM N/A
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)5.63%
ROE(5y)6.16%
ROIC(3y)4.1%
ROIC(5y)4.24%
ROICexc(3y)4.63%
ROICexc(5y)4.82%
ROICexgc(3y)4.81%
ROICexgc(5y)5.01%
ROCE(3y)6.32%
ROCE(5y)6.56%
ROICexgc growth 3Y-40.81%
ROICexgc growth 5Y-24.33%
ROICexc growth 3Y-40.44%
ROICexc growth 5Y-24.35%
OM growth 3Y-27.15%
OM growth 5Y-15.85%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.32%
GM growth 5Y-1.26%
F-Score6
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA 6.86
Cap/Depr 211.44%
Cap/Sales 14.1%
Interest Coverage 2.15
Cash Conversion 10.96%
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 0.86
Altman-Z 1.28
F-Score6
WACC3.28%
ROIC/WACC0.4
Cap/Depr(3y)285.57%
Cap/Depr(5y)222.94%
Cap/Sales(3y)15.49%
Cap/Sales(5y)11.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.25%
Revenue growth 3Y-0.64%
Revenue growth 5Y0.07%
Sales Q2Q%6.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y242.27%
EBIT growth 3Y-27.62%
EBIT growth 5Y-15.79%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.89%
OCF growth 3Y-14.16%
OCF growth 5Y0.18%

GASCOGNE / ALBI.PA FAQ

What is the fundamental rating for ALBI stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALBI.PA.


What is the valuation status of GASCOGNE (ALBI.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to GASCOGNE (ALBI.PA). This can be considered as Overvalued.


Can you provide the profitability details for GASCOGNE?

GASCOGNE (ALBI.PA) has a profitability rating of 2 / 10.


What is the financial health of GASCOGNE (ALBI.PA) stock?

The financial health rating of GASCOGNE (ALBI.PA) is 1 / 10.